Century Therapeutics closes its Seattle hub amid wider cuts, departure of R&D head Century Therapeutics is closing its Seattle operations as part of a 25% reduction in headcount and a shift in its… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Bristol Myers Squibb and Century Therapeutics’ deal for $150M could boost Seattle cell research Cell therapy company Century Therapeutics will receive a $100 million up front payment and $50 million in equity investment from… Read More
